Germany seeks ban on gay conversion therapies
German Health Minister Jens Spahn said Friday he will seek to ban conversion therapies that claim to change sexual orientation.
22 hours ago
0
0
German Health Minister Jens Spahn said Friday he will seek to ban conversion therapies that claim to change sexual orientation.
22 hours ago
0
0
Almost three quarters (70%) of biomedical research papers do not report outcomes for men and women, according to a new analysis of over 11.5 million medical research papers published between 1980 and 2016. Additionally, female ...
Feb 08, 2019
0
1
An advocacy group has asked federal regulators to investigate Brown University's medical school, arguing it is violating the law by using live pigs for training in emergency medicine.
Jan 30, 2019
0
1
Around the country, women physician researchers make 7 to 8 percent less per year than men. At the Johns Hopkins University School of Medicine, efforts to eliminate such a gender disparity have cut the difference in salaries ...
Jan 28, 2019
0
0
(HealthDay)—The holidays, winter weather, and the flu season have all prompted a blood shortage, the American Red Cross warns.
Jan 15, 2019
0
0
More than half of female surgeons in the UK have faced or witnessed discrimination in the workplace, suggest the results of a confidential online poll, published in the online journal BMJ Open.
Jan 07, 2019
0
2
Pharmaceutical giant Eli Lilly announced Monday it will acquire Loxo Oncology for around $8 billion, the latest big transaction aimed at developing and monetizing new treatments for cancer.
Jan 07, 2019
0
0
A woman said to have been in a vegetative state for at least a decade at a private health care facility in Phoenix reportedly gave birth recently, triggering a police investigation and reviews by state agencies in a situation ...
Jan 05, 2019
1
6
Should death be defined in strictly biological terms—as the body's failure to maintain integrated functioning of respiration, blood circulation, and neurological activity? Should death be declared on the basis of severe ...
Jan 04, 2019
1
4
In an editorial published in CNS Spectrums, Jay Avasarala, MD, Ph.D., takes the research community to task for its lack of minority representation in Phase III clinical trials for drugs to treat Multiple Sclerosis (MS).
Jan 01, 2019
0
5